Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1

Journal of Immunology

Volumn 188, Issue 6, 2012, Pages 2509-2515

  Glasner, Ariella ^a   Ghadially, Hormas ^a   Gur, Chamutal ^a   Stanietsky, Noa ^a   Tsukerman, Pinchas ^a   Enk, Jonatan ^a   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CANCER PREVENTION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEWIS CARCINOMA; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANIMALS; ANTIGENS, LY; CARCINOMA, LEWIS LUNG; CELL SEPARATION; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS;

EID: 84857868836     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102461     Document Type: Article

References (38)

1. Kärre, K., H. G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319: 675-678. (Pubitemid 16119452)
2. Arnon, T. I., G. Markel, and O. Mandelboim. 2006. Tumor and viral recognition by natural killer cells receptors. Semin. Cancer Biol. 16: 348-358. (Pubitemid 44311503)
3. Moretta, A., C. Bottino, M. C. Mingari, R. Biassoni, and L. Moretta. 2002. What is a natural killer cell? Nat. Immunol. 3: 6-8. (Pubitemid 34065607)
4. Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M. C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19: 197-223. (Pubitemid 32368034)
5. Welte, S., S. Kuttruff, I. Waldhauer, and A. Steinle. 2006. Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Nat. Immunol. 7: 1334-1342. (Pubitemid 46111255)
6. Malmberg, K. J., and H. G. Ljunggren. 2009. Spotlight on IL-22-producing NK cell receptor-expressing mucosal lymphocytes. Nat. Immunol. 10: 11-12.
7. Gazit, R., R. Gruda, M. Elboim, T. I. Arnon, G. Katz, H. Achdout, J. Hanna, U. Qimron, G. Landau, E. Greenbaum, et al. 2006. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 7: 517-523.
8. Mandelboim, O., N. Lieberman, M. Lev, L. Paul, T. I. Arnon, Y. Bushkin, D. M. Davis, J. L. Strominger, J. W. Yewdell, and A. Porgador. 2001. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409: 1055-1060. (Pubitemid 32204059)
9. DeNardo, D. G., M. Johansson, and L. M. Coussens. 2008. Immune cells as mediators of solid tumor metastasis. Cancer Metastasis Rev. 27: 11-18.
10. Fidler, I. J. 2003. The pathogenesis of cancer metastasis: the "seed and soil"hypothesis revisited. Nat. Rev. Cancer 3: 453-458. (Pubitemid 37328849)
11. Loberg, R. D., D. A. Bradley, S. A. Tomlins, A. M. Chinnaiyan, and K. J. Pienta. 2007. The lethal phenotype of cancer: the molecular basis of death due to malignancy. CA Cancer J. Clin. 57: 225-241. (Pubitemid 47312082)
12. Lakshmikanth, T., S. Burke, T. H. Ali, S. Kimpfler, F. Ursini, L. Ruggeri, M. Capanni, V. Umansky, A. Paschen, A. Sucker, et al. 2009. NCRs and DNAM- 1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. J. Clin. Invest. 119: 1251-1263.
13. Halfteck, G. G., M. Elboim, C. Gur, H. Achdout, H. Ghadially, and O. Mandelboim. 2009. Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1. J. Immunol. 182: 2221-2230.
14. Elboim, M., R. Gazit, C. Gur, H. Ghadially, G. Betser-Cohen, and O. Mandelboim. 2010. Tumor immunoediting by NKp46. J. Immunol. 184: 5637-5644.
15. Arnon, T. I., H. Achdout, N. Lieberman, R. Gazit, T. Gonen-Gross, G. Katz, A. Bar-Ilan, N. Bloushtain, M. Lev, A. Joseph, et al. 2004. The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood 103: 664-672. (Pubitemid 38140102)
16. Alter, G., J. M. Malenfant, and M. Altfeld. 2004. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294: 15-22. (Pubitemid 39626587)
17. Achdout, H., T. Meningher, S. Hirsh, A. Glasner, Y. Bar-On, C. Gur, A. Porgador, M. Mendelson, M. Mandelboim, and O. Mandelboim. 2010. Killing of avian and swine influenza virus by natural killer cells. J. Virol. 84: 3993-4001.
18. Eccles, S. A., and D. R. Welch. 2007. Metastasis: recent discoveries and novel treatment strategies. Lancet 369: 1742-1757. (Pubitemid 46755391)
19. Pantel, K., R. H. Brakenhoff, and B. Brandt. 2008. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat. Rev. Cancer 8: 329-340. (Pubitemid 351596394)
20. Eschwège, P., F. Dumas, P. Blanchet, V. Le Maire, G. Benoit, A. Jardin, B. Lacour, and S. Loric. 1995. Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy. Lancet 346: 1528-1530.
21. Holmgren, L., M. S. O'Reilly, and J. Folkman. 1995. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med. 1: 149-153.
22. Klein, H. G. 1999. Immunomodulatory aspects of transfusion: a once and future risk? Anesthesiology 91: 861-865. (Pubitemid 29418669)
23. Glasner, A., R. Avraham, E. Rosenne, M. Benish, O. Zmora, S. Shemer, H. Meiboom, and S. Ben-Eliyahu. 2010. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a β-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J. Immunol. 184: 2449-2457.
24. Takeda, K., M. J. Smyth, E. Cretney, Y. Hayakawa, N. Yamaguchi, H. Yagita, and K. Okumura. 2001. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-γ-dependent suppression of subcutaneous tumor growth. Cell. Immunol. 214: 194-200. (Pubitemid 34499473)
25. Smyth, M. J., D. I. Godfrey, and J. A. Trapani. 2001. A fresh look at tumor immunosurveillance and immunotherapy. Nat. Immunol. 2: 293-299. (Pubitemid 33706339)
26. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274. (Pubitemid 40563170)
27. Gur, C., A. Porgador, M. Elboim, R. Gazit, S. Mizrahi, N. Stern-Ginossar, H. Achdout, H. Ghadially, Y. Dor, T. Nir, et al. 2010. The activating receptor NKp46 is essential for the development of type 1 diabetes. Nat. Immunol. 11: 121-128.
28. Gur, C., J. Enk, S. A. Kassem, Y. Suissa, J. Magenheim, M. Stolovich-Rain, T. Nir, H. Achdout, B. Glaser, J. Shapiro, et al. 2011. Recognition and killing of human and murine pancreatic b cells by the NK receptor NKp46. J. Immunol. 187: 3096-3103.
29. Jarahian, M., M. Fiedler, A. Cohnen, D. Djandji, G. J. Hämmerling, C. Gati, A. Cerwenka, P. C. Turner, R. W. Moyer, C. Watzl, et al. 2011. Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin. PLoS Pathog. 7: e1002195.
30. Andrews, D. M., C. E. Andoniou, F. Granucci, P. Ricciardi-Castagnoli, and M. A. Degli-Esposti. 2001. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat. Immunol. 2: 1077-1084. (Pubitemid 33069504)
31. Andrews, D. M., A. A. Scalzo, W. M. Yokoyama, M. J. Smyth, and M. A. Degli-Esposti. 2003. Functional interactions between dendritic cells and NK cells during viral infection. Nat. Immunol. 4: 175-181. (Pubitemid 36193020)
32. Andoniou, C. E., S. L. van Dommelen, V. Voigt, D. M. Andrews, G. Brizard, C. Asselin-Paturel, T. Delale, K. J. Stacey, G. Trinchieri, and M. A. Degli- Esposti. 2005. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat. Immunol. 6: 1011-1019. (Pubitemid 41486186)
33. Magri, G., A. Muntasell, N. Romo, A. Sáez-Borderías, D. Pende, D. E. Geraghty, H. Hengel, A. Angulo, A. Moretta, and M. López-Botet. 2011. NKp46 and DNAM-1 NK cell receptors drive the response to human cytomegalovirus infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 117: 848-856.
34. Stern-Ginossar, N., and O. Mandelboim. 2009. An integrated view of the regulation of NKG2D ligands. Immunology 128: 1-6.
35. Arnon, T. I., H. Achdout, O. Levi, G. Markel, N. Saleh, G. Katz, R. Gazit, T. Gonen-Gross, J. Hanna, E. Nahari, et al. 2005. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat. Immunol. 6: 515-523. (Pubitemid 41716765)
36. Pogge von Strandmann, E., V. R. Simhadri, B. von Tresckow, S. Sasse, K. S. Reiners, H. P. Hansen, A. Rothe, B. Böll, V. L. Simhadri, P. Borchmann, et al. 2007. Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity 27: 965-974. (Pubitemid 350251218)
37. Brandt, C. S., M. Baratin, E. C. Yi, J. Kennedy, Z. Gao, B. Fox, B. Haldeman, C. D. Ostrander, T. Kaifu, C. Chabannon, et al. 2009. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J. Exp. Med. 206: 1495-1503.
38. Groh, V., J.Wu, C. Yee, and T. Spies. 2002. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419: 734-738. (Pubitemid 35177960)